Brief: Adamis Pharmaceuticals Corp QTRLY Loss Per Share $0.06

DMK Pharmaceuticals

10/08/2022 21:16

Aug 10 (Reuters) - Adamis Pharmaceuticals Corp  ADMP.O :
    * ADAMIS PHARMACEUTICALS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * ADAMIS PHARMACEUTICALS CORP QTRLY LOSS PER SHARE $0.06
    * ADAMIS PHARMACEUTICALS CORP - CASH AND CASH EQUIVALENTS AT
END
OF Q2 TOTALED $8.9 MILLION.

Source text for Eikon:  ID:nGNX1vlhbV 
Further company coverage:  ADMP.O 

 ((Reuters.Briefs@thomsonreuters.com;))